Skip to main content
SMMT logo

Summit Therapeutics Inc.

SMMTNASDAQHealthcareBiotechnology

$14.63Today:- (-)1Y −26.77%

As of Oct 16, 2026 close

Market cap
$11.96B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$12.07$29.23
Volume (live)
-
Avg. volume (3M)
6.83M

Summit Therapeutics Inc. (SMMT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Summit Therapeutics Inc. stock.

Analyst Consensus Rating

Investment consensus from 17 professional research analysts

Consensus Rating

Buy
Based on 17 unique analysts
(18 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$26.79
+83.12% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest SMMT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Etzer Darout
Barclays
HoldMaintains
$18.00 → $20.00
Dara Azar
Stifel Nicolaus
BuyMaintains
-
Mitchell Kapoor
HC Wainwright
HoldReiterates
-
Kelsey Goodwin
Piper Sandler
HoldMaintains
$16.00
Unknown Analyst
Leerink Partners
HoldReiterates
$11.00 → $13.00
Faisal Khurshid
Jefferies
BuyMaintains
-
David Dai
UBS
BuyMaintains
$33.00
Cory Kasimov
Evercore ISI Group
BuyMaintains
$34.00
David Dai
UBS
BuyMaintains
$33.00
Mohit Bansal
Wells Fargo
BuyMaintains
$30.00
Jeffrey Walch
Bernstein
HoldMaintains
$11.90
Salveen Richter
Goldman Sachs
BuyMaintains
$41.00
Mara Goldstein
Clear Street
BuyReiterates
$31.00
Kalpit Patel
Wolfe Research
HoldMaintains
-
Edmund Ingham
Forbes
HoldInitiates Coverage
-
Tyler Van Buren
TD Cowen
BuyMaintains
-
Bradley Canino
Guggenheim
BuyInitiates Coverage
$40.00 → $38.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 5, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for SMMT?

The analyst consensus rating for SMMT is Buy, based on the latest ratings from 17 analysts over the last 90 days.

What is the average price target for SMMT?

The average 12-month price target for SMMT is $26.79, representing an upside of 83.1% from the Oct 16, 2026 close of $14.63.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.